AHCO
AdaptHealth Corp. · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow -1.1% ·
net new positions -8.3%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 109.95K | $661,406 | n/a | n/a |
| Q2 2026 | 90 | -1 | 72.87M | $759.46M | +5 | −6 |
| Q1 2026 | 94 | +1 | 70.41M | $837.57M | +8 | −7 |
| Q4 2025 | 93 | +1 | 73.49M | $731.97M | +1 | n/a |
| Q3 2025 | 16 | +1 | 45.46M | $406.86M | +2 | −1 |
| Q2 2025 | 12 | -1 | 44.17M | $416.50M | +2 | −3 |
| Q1 2025 | 10 | +2 | 8.72M | $94.54M | +3 | −1 |
| Q4 2024 | 8 | -2 | 7.78M | $74.03M | n/a | −2 |
| Q3 2024 | 9 | +1 | 7.21M | $80.97M | +1 | n/a |
| Q2 2024 | 8 | n/a | 4.34M | $43.45M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 15.12M | n/a | $142.56M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 2 | The Vanguard Group ✦ (passive) | 11.85M | n/a | $111.78M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 8.98M | n/a | $84.68M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passive) | 4.36M | -0.6% | $41.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 2.46M | -4.0% | $23.23M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | AQR Capital Management ✦ | 423.57K | +64.7% | $3.99M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 7 | Arrowstreet Capital ✦ | 386.32K | New | $3.64M | 0.0% | New | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 238.63K | -37.5% | $2.25M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 226.26K | -45.1% | $2.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 81.55K | +4.2% | $770,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 20.00K | New | $188,600 | 0.0% | New | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 14.67K | -81.8% | $138,357 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $3.64M | 0.0% |
| Adage Capital Partners | $188,600 | 0.0% |
Exited
| Citadel Advisors | $3.36M | was 0.0% |
| Marshall Wace | $1.49M | was 0.0% |
| Two Sigma Investments | $1.20M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 239 holders, 141.33M shares, $1.65B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 20.00K sh @ 5.86 · $117,200
Director · 20.00K sh @ 6.37 · $127,400
Director · 23.50K sh @ 6.38 · $149,930
Open-market sales (S)
No open-market insider sales in our coverage window.
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology